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Abstract
Background: KCNH1 encodes a voltage-gated potassium channel that is predominantly expressed in the central
nervous system. Mutations in this gene were recently found to be responsible for Temple-Baraitser Syndrome
(TMBTS) and Zimmermann-Laband syndrome (ZLS).
Methods: Here, we report a new case of TMBTS diagnosed in a Lebanese child. Whole genome sequencing was
carried out on DNA samples of the proband and his parents to identify mutations associated with this disease.
Sanger sequencing was performed to confirm the presence of detected variants.
Results: Whole genome sequencing revealed three missense mutations in TMBTS patient: c.1042G > A in KCNH1, c.
2131 T > C in STK36, and c.726C > A in ZNF517. According to all predictors, mutation in KCNH1 is damaging de novo
mutation that results in substitution of Glycine by Arginine, i.e., p.(Gly348Arg). This mutation was already reported in
a patient with ZLS that could affect the connecting loop between helices S4-S5 of KCNH1 with a gain of function
effect.
Conclusions: Our findings demonstrate that KCNH1 mutations cause TMBTS and expand the mutational spectrum
of KCNH1 in TMBTS. In addition, all cases of TMBTS were reviewed and compared to ZLS. We suggest that the two
syndromes are a continuum and that the variability in the phenotypes is the result of the involvement of genetic
modifiers.
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Background
Temple-Baraitser syndrome (TMBTS; MIM: 611816)
and Zimmerman-Laband syndrome (ZLS; MIM: 135500)
are rare developmental disorders with hypoplasia/aplasia
of nails. These syndromes are considered to be distinct
entities, with TMBTS defined as a disorder characterized
by severe intellectual disability (ID), epilepsy, hypopla-
sia/aplasia of the nails of the thumb and great toe, a
pseudo-myopathic appearance, and marked hypotonia in
infancy [1–6], and ZLS charatacterized by ID, gingival
fibromatosis, associated with absence or dysplasia of all
nails, hypoplasia of the distal phalanges, scoliosis,
hepato-splenomegaly, coarse face, and hirsutism [7].
KCNH1 encodes a voltage-gated potassium channel
that is predominantly expressed in the central nervous
system, and mutations in this gene have been linked to
both syndromes [6, 7].
Here, we report on a Lebanese male patient with
TMBTS having a mutation in KCNH1 that has previ-
ously been reported in a patient with ZLS. In addition,
we have reviewed all published cases of TMBTS and
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highlight common features, as well as critical differences,
between these two syndromes, and raise the issue of




The male proband is the third child of healthy unrelated
Lebanese parents. He was born at 36 weeks of gestation,
after a complicated pregnancy characterized by the
therapeutic administration, to the mother, of drugs
against early contractions at 32 weeks of gestation. At
birth, his weight was 2700 g (60th percentile), his length
48 cm (75th percentile) and his head circumference
(OFC) 33 cm (60th percentile). Family history was unre-
markable. Marked hypotonia, constipation, and aplasia
of thumb and great toe nails were noted in the first two
to three days of life.
The propositus was referred for genetic examin-
ation at the age of 9 months. His weight was 9750 g
(60th percentile), length 71.5 cm (75th percentile),
OFC 42.7 cm (10th percentile). He had a flat occiput,
a frontal bossing, large ears, mild hypertelorism, epi-
canthal folds, a broad and depressed nasal bridge, a
short columella, long philtrum, a broad mouth with
downturned corners, a high arched palate, 2 upper
and 2 lower incisors of normal shape, and full
cheeks (Fig. 1). Widely spaced nipples and left chest
depression were also noted. Both thumbs were held
in an adducted posture and were terminally broad
with aplasia of the nails bilaterally. Big toes were
also broad, long, and with aplasia of nails. No hirsut-
ism, no hypoplasia of the distal phalanges, no hyper-
mobility, no camptodactyly, nor palmar creases were
noted.
At 15 months old, his weight was 11 kg (75th percent-
ile), length 79 cm (50th percentile), and OFC 45.7 cm
(10th percentile). Delays in developmental milestones
were striking, as he could not stand up alone or walk
with help, and could not follow or respond to simple
commands. He had a myopathic face with poor visual
contact, a wide open mouth and mild gingival enlarge-
ment (Fig. 1). Skeletal survey revealed nearly absent dis-
tal phalanges of the thumbs and great toes, very small
femoral and humeral epiphyses, and an osteosclerosis of
the anterior arc of the right 10th rib (Fig. 2).
Magnetic resonance imaging, abdominal and heart
ultrasound, brain stem auditory evoked responses,
and EEG were normal. Complete blood count,
hemoglobin electrophoresis, serum electrolytes, blood
glucose levels, urinalysis, thyroid, liver and renal func-
tion tests were all unremarkable. Array CGH analysis
and Chromosomal Microarray Analysis did not reveal
any abnormalities (data not shown).
DNA extraction and Whole Genome Sequencing (WGS)
Whole genome sequencing was carried-out on the pa-
tient and his parents using the HiSeq 2500 sequencer
(Illumina, San Diego, CA, USA). Libraries were gener-
ated from 1 μg of genomic DNA [8] using the Illumina
TruSeq DNA PCR-Free Sample Preparation Kit. Gen-
omic DNA was sheared using the Covaris system (Wo-
burn, MA, USA). Isolated DNA fragment ends were
blunted, A-tailed and ligated with sequencing adaptors
with index sequences. Excess adapters and enzymes were
removed using AMPure beads (Beckman Coulter Gen-
omics, Danvers, MA, USA). Indexed libraries were size
selected to 350 bp range using bead-based capture and
the concentration of amplifiable fragment was deter-
mined by qPCR relative to sequencing libraries with
known concentration. Normalized libraries were clus-
tered on a c-BOT machine and 125 bp paired-end se-
quencing was performed on the HiSeq2500 system.
Fig. 1 Photographs of the patient at the age of 9 and 15 months.
Note the frontal bossing, mild hypertelorism, broad and depressed
nasal bridge, broad mouth with downturned corners, full cheeks and
the myopathic face. Both thumbs are held in an adducted posture
are terminally broad with aplasia of the nails bilaterally. Big toes are
also broad, long, with aplasia of nails
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WGS data analyses
Raw data was mapped to the human genome reference
build 19 (http://www.broadinstitute.org/ftp/pub/seq/ref-
erences/Homo_sapiens_assembly19.fasta) using BWA
aligner [9] version 0.7.7-r441 and variant call was per-
formed using GATK [10] version 3.3.2. The rare variant
analysis was performed using the xbrowse tool (https://
xbrowse.broadinstitute.org/). For the parents and the
child, a ‘De novo Dominant’ inheritance model was se-
lected, with severity of the variant effect set to ‘moderate
to high impact’ (Nonsense, essential splice sites, mis-
sense frameshift and in frame), call quality as high
(genotype quality > 20 and allele balance ratio > 25 %)
and allele frequency < 1 % in 1000 genomes and The Ex-
ome Aggregation Consortium (ExAC) v0.3 datasets.
Functional consequences of amino acid substitutions
have been predicted using various tools [11–14].
Sanger sequencing
Genomic sequences of KCNH1, STK36, and ZNF517 were
obtained from UCSC Genome Browser (December 2013).
A flanking region around each sequence variant site
was amplified by PCR with the following primer pairs:
forward primer (5′-TCAACGCTTTTGAGAACGTG-3′)
and reverse primer (5′-TGTCTTGGTGTCCTCGTCAA-
3′) for KCNH1 (NM_002238); forward primer (5′-
CATCCCTCATCTCTGGCCTG-3′) and reverse primer
(5′-ACTTTTACCTTGCCCTGAATCA-3′) for STK36
(NM_001243313); and forward primer (5′-TTCAA
GCAAAGCTCCATCCT-3′) and reverse primer (5′-
GGTGTGGAACTTCTGGTGCT-3′) for ZNF517 (NM_
213605). Primers for the PCR amplifications were de-
signed using Primer3 Software. PCR reactions were per-
formed using Taq DNA polymerase (Invitrogen Life
Technologies, Carlsbad, CA, USA). PCR fragments were
run on 1 % agarose gel. The fragments were purified using
the Illustra_ GFX_ PCR DNA and Gel Band Purification
Kit (GE Healthcare) and then sequenced using the Big
Dye_ Terminator v 1.1 Cycle Sequencing Kit (Applied
Biosystems, Foster City, CA, USA). Sequence reaction was
purified on Sephadex G50 (Amersham Pharmacia Biotech,
Foster City, CA), and then loaded into an ABI 3100 sys-
tem after the addition of Hidi formamide. Electrophero-
grams were analyzed using Sequence Analysis Software
version 5.2 (Applied Biosystems) and then aligned with
the reference sequences using ChromasPro version 1.22
(Technelysium, Queensland, Australia).
Results
Whole Genome Sequencing identified 3 missense muta-
tions in TMBTS patient (Table 1). We validated and
confirmed the de novo origin of these variants by Sanger
sequencing.
The mutation in KCNH1 (c.1042G > A) has a dam-
aging effect according to all different effect predictors
tested. STK36 has a missense mutation (c.2131 T > C),
which also has damaging effects according to half of the
effect predictors tested. ZNF517 has a missense muta-
tion (c.726C > A) predicted as disease causing by one of
the effect predictors.
The KCNH1 mutation results in a substitution of Gly-
cine by Arginine. Same mutation is found in both iso-
forms of this protein: p.(Gly348Arg) in short isoform
(NM_002238.3) and p.(Gly348Arg) in long isoform
(NM_172362) in the ion transport domain. The
p.(Gly348Arg) mutation maps to the connecting loop
Fig. 2 X-ray films of the patient. Note the absent distal phalanges of
the thumbs and great toes, and the very small femoral epiphyses at
the age of 15 months
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between helices S4-S5 as reported by Kortum et al., and
exerts a strong impact on function [18].
Discussion
We report on a male Lebanese patient in which a de
novo missense heterozygous mutation c.1042G > A in
the KCNH1 gene led to TMBTS.
KCNH1 is a member of voltage-gated potassium chan-
nel proteins. It is recognized as an important regulator
of cell proliferation in bone-marrow derived mesenchy-
mal stem cells, and is involved in fundamental cellular
and developmental processes [15, 16].
Mutations in KCNH1 have been recently associated
with TMBTS [6]. Moreover, de novo gain-of-function
mutations in KCNH1 have also been reported in individ-
uals with ZLS [7].
Generally, TMBTS and ZLS can be distinguished by
their characteristic phenotypic features, which include
absence or dyplasia of all nails and hypertrichosis in ZLS
vs hypoplasia or aplasia of only the great toe and
thumb’s nails in TMBTS (Table 2). With this in mind,
we considered that our patient had TMBTS. These syn-
dromes are currently considered to be two separate en-
tities, but their common characteristics suggest that
these two syndromes may be different presentations of
the same disorder. In fact, many common characteristics
of patients with TMBTS and ZLS have been noted, such
as, seizures, hypertrichosis, hypotonia, aplasia of nails,
etc., which sometimes occur in some but not all patients
(Table 2). It is noteworthy to mention that many clinical
databases do not even mention TMBTS as a differential
diagnosis for ZLS because of the absence of hypertricho-
sis, even though not all reported patients with ZLS
present this characteristic.
Interestingly, the same mutation (c.1042G > A) identi-
fied in our patient has never been reported with TMBTS,
but was previously detected in patients with ZLS (pa-
tient 7 in Abo-Dalo et al. or subject 3 in Kortüm et al.)
[17, 18]. This substitution leads to a gain of function ef-
fect and mutants carrying this mutation exhibit an accel-
erated channel activation and a slower deactivation [18].
Along with the previously identified p.(Ile494Val) mis-
ense variant in KCNH1, which was shared among indi-
viduals with TMBTS and ZLS, the genetic defect
identified in our patient, i.e., p.(Gly348Arg) was found in
patients bearing different phenotypes and thus sup-
posedly different syndromes. This provides stronger evi-
dence that both syndromes clearly overlap and could be
a phenotypic continuum. In fact, the mutation
c.1042G > A was found in a patient with ZLS who does
not present with hypertrichosis, similar to the patient re-
ported herein. However, the patient had in addition,
aplasia of all nails of hands and feet, thoracic scoliosis,
and infrequent seizures, which were not present in our
patient who had a delay in epiphyseal maturation,
(Table 3) a feature never reported before in both entities,
and gingival enlargement. The latter is a characteristic
not reported previously in TMBTS affected individuals,
however it is a frequent feature in patients with muta-
tions of KCNH1 (Bramswig et al.). Genetic modifiers,
possibly involving the Na+ and Ca2+ channels, might
block the KCNH1 channels and result in the gingival en-
largement as it is observed in individuals treated with
Na+ blocker phenytoin or Ca2+ channel blocker nifedi-
pine [18].
On the other hand, the patient reported by Kortum et
al., developed seizures in adolescence, therefore one
could speculate a late occurence of epilepsy in the pa-
tient described here with the same mutation. Yet,
Bramswig et al. described 3 individuals presenting with
an identical KCNH1 variant but with different clinical
features with regard to epilepsy [19]. Consequently, the
presence of a pathogenic KCNH1 variant alone could
not allow for a prediction of occurence of epileptic
seizure.
Other genetic modifiers could be responsible for the ob-
served differences in clinical phenotype. We looked deeper
at the results of the WGS and noticed mutations in two
other genes STK36 and ZNF517, which were classified in
some databases as possibly damaging. However, their sig-
nificance remains to be elucidated. Recently, de novo muta-
tions in STK36 have been identified in patients with
epileptic encephalopathies [20]. Although our patient who
has missense mutation in STK36 does not present with epi-
lepsy at present, he might develop it in adolescence as in
patient 3 in Kortum et al. Thus, concordant to previous re-
ports, our data supports the evidence that the mutated
KCNH1 is a major cause of TMBTS and ZLS, while other
Table 1 Variants identified with the WGS analysis while running
a de novo dominant model using xbrowse
Gene Position Function Software prediction
KCNH1 chr1:211093321 Missense Polyphen: probably damaging
C > T c.1042G > A Sift: damaging
p.(Gly348Arg) Mutation taster: disease
causing
Fathmm: damaging
STK36 chr2:219558050 Missense Polyphen: possibly damaging
T > C c.2131 T > C Sift: damaging
p.(Cys711Arg) Mutation taster: disease
causing
Fathmm: tolerated
ZNF517 chr8:146033027 Missense Mutation taster:disease
causing
C > A c.726C > A
p.(Phe242Leu)
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Table 2 Review of all cases with the Temple-Baraitser Syndrome and a comparison to the Zimmermann-Laband syndrome characteristics
Temple Baraitser Syndrome (TMBTS)









1 or Simons et al.
(2014) Patient D
Jacquinet et al. (2010)
[3] Patient 2 or Simons
et al. (2014) Patient E
Yesil et al. (2013)
or Simons et al.
(2014) Patient C
Shen (2015) [5]
Patient 1 or Simons
et al. (2014) Patient F
Shen (2015) [5] Patient






Complicated Prgenancy + - + - - - - +
Milestone
Birth weight 2,700 g (60th
percentile)
3,370 ga 3,980 g (90th
centile)
3,590 g (50th centile) 2,980 g (40th centile) 3,600 g (50th
percentile)
7 pounds 7 ounces 3,544 g (50th centile)
Height at birth 48 cm (75th
percentile)






35.5 cma ND 34 cm (30th centile) 33 cm (40th centile)
Clinical findings
Age (years) 09/12 35/12 44/12 610/12 11/12 37/12 09/12 56/12




+ + + + + + + + and of all fingers 8/8
Absence/hypoplasia
of hallux nail
+ + + + + + + + 8/8
Broad thumbs
terminally
+ - + + + + - + 6/8
Thumbs; long/proximaly
set
+ ND + + + + + + 7/7
Adductus deformity
of distal thumb
+ ND + + + + + + 7/7
Pseudoepiphysis of
the thumb
- - + + + ND ND ND 3/5
Pseudoepiphysis of
the great toe





- + + + + + no but malpatterned no but malpatterned 5/8
Hypoplasia of distal
phalanges (II-V)
- + + - + + + + 6/8
Delay in epiphyseal
maturation
+ ND ND ND ND ND ND ND
Neurologic
Intellectual disability + + + + N/A + + + 7/7
Poor visual contact + + ND + + + ND ND 5/5
Autistic behavior - + + ND ND + ND ND 3/4
Seizures - ND + + + + One seizure + 6/7
Hypotonia/motor
retardation


















Table 2 Review of all cases with the Temple-Baraitser Syndrome and a comparison to the Zimmermann-Laband syndrome characteristics (Continued)
Hearing loss - ND ND ND ND ND ND ND
Abnormal MRI findings - Widespread
cerebral
atrophy




Thoracic abnormalities + ND ND ND - ND ND ND
Spine abnormalities - ND ND ND ND ND ND ND
Coarse face + ND ND ND ND ND ND ND
Myopathic appearance + ND + + + + + + 7/7
Low anterior hairline - + ND ND ND ND + High anterior hairline
Coarse thick hair - ND + Hypertrichosis - + ND ND
Flat forehead Bulging + + + + + ND ND 5/6
Mild hypertelorism + + - + + + + + 7/8
Epicanthal folds + - + - + + - - 4/8
Broad depressed
nasal bridge
+ + + + + + + + 8/8
Short columella + - + + + + - + 6/8
Long philtrum + + + + + + + + 8/8
Thick/full vermillion
border of upper lip
- ND + + + Upper and lower lip Upper and
lower lips
Tented vermilion of






+ ND + + + + + + 7/7
Gingival enlargement + - - - - - - - 1/8
Narrow and high
palate
+ ND + ND ND ND + ND









reflux in the neonatal
period
ND Constipation - Constipation
Small genitalia/endocrine
anomalies
- ND ND ND ND + ND ND
Cardiovascular system
anomalies



















Castori et al.(2013) Zimmermann-Laband



















ND ND ND ND ND ND ND
2,710 g 2,850 g 3,354 g NA
45 cm 50 cm 52 cm NA
34 cm 35 cm NA NA
141/12 44/12 39/12 13







- - - -
5/6 2/2 + + + +
ND 0/4 ND - - + -
ND 3/4 ND + - - +
N D ND ND ND ND ND ND
ND ND ND ND ND ND ND
ND ND ND ND ND ND ND








ND ND ND ND
ND ND ND ND ND ND ND
21/52 6/6 2/2 + + + +
ND ND ND ND + + +
ND ND ND ND + + ND
7/52 6/6 0/2 (patients ages: 22
and 5 years)
+ - + +
6/52 6/6 2/2 + + + +
ND ND ND ND ND ND ND
2/52 1/4
2 NA










1 has Pectus carinatum
and thoracic kyphosis.
Others ND














Table 2 Review of all cases with the Temple-Baraitser Syndrome and a comparison to the Zimmermann-Laband syndrome characteristics (Continued)
8/52 5/6 Scoliosis 1 Scoliosis ND ND ND ND
at least 1. Others ND 6/6 2/2 ND ND + ND
ND 4/5 ND + + + +




Hypertrichosis 3/6 Marked hypertrichosis 2/2 + + + +
ND ND ND Prominent ND Broad and
prominent
ND
6/52 4/5 ND + + + +
ND 1/6 ND - + + -
ND 3/4 depressed
5/5 broad
ND + + + Only broad




1/2 ND ND ND ND
27 thick lips/macrostomia 5/6 ND + + + +
ND 4/4 ND + + + +
52/52 5/6 2/2 + + + +
11/52 ND ND ND ND ND ND
ND ND ND ND ND ND ND
ND 3/6 have gastroesophageal
reflux and/or constipation






ND 1 has macroorchidism ND ND ND ND
6/52 ND ND - ND - Open ductus
bodalli
Abbreviations: +, present; −, absent; NA not analyzed, ND not documented, N/A not applicable, MRI magnetic resonance imaging














Table 3 Clinical comparison between the patient here described with TMBTS and the patient described by Kortüm et al. (subject 3)
Patients having the p.(Gly348Arg) mutation
Present patient Subject 3 in Kortüm et al. (2015)
Gender M F
Complicated Pregnancy + ND
Milestone
Birth weight 2.700 g (60th percentile) 3,290 g (39 weeks) (54th percentile)
Height at birth 48 cm (75th percentile) 55 cm (99th percentile)
Head circumference at birth 33 cm (60th percentile) ND
Clinical findings
Age (years) 09/12 19
Consanguinity - ND
Limbs
Absence of nails Nails of thumb and hallux Nails of hands and feet
Broad, long thumbs terminally + ND
Adductus deformity of distal thumb + ND
Hypoplasia of terminal phalanges of hands and feet Nearly absent +
Delay in epiphyseal maturation + ND
Neurologic
Intellectual disability + Severe
Poor visual contact + ND
Seizures - Started in adolescence
Hypotonia/motor retardation + +
Hearing loss - -
Abnormal MRI findings - NA
Dysmorphic features
Thoracic abnormalities + Thoracic scoliosis
Coarse face - +
Myopathic appearance + ND
Hypertrichosis - -
Coarse thick hair - -
Flat forehead Bulging ND
Mild hypertelorism + ND
Epicanthal folds + ND
Broad depressed nasal bridge + ND
Short columella + ND
Long philtrum + ND
Thick vermillion border of upper lip - ND
Broad mouth with downturned corners + ND
Gingival enlargement + Noticed in childhood prior anticonvulsant treatment
Central incisors + +
Narrow and high palate + ND
Inverted nipples Widely spaced ND
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genes can act as disease modifying roles. Understanding the
molecular mechanisms by which these genes exert disease
modifying roles might help in the better understanding of
the pathogenesis of these syndromes.
Finally, both ZLS and TMBTS patients with KCNH1
mutations show similar phenotypes. Nevertheless, two
other ZLS patients were also described with mutations
in the ATP6V1B2 gene that encodes a component of the
vacuolar ATPase (V-ATPase). These mutations present a
more pronounced phenotype characterized mostly by
hypertrichosis and a coarser facial phenotype (Table 2).
But due to the limited number of individuals described,
a conclusion about whether probands with mutations in-
volving ATP6V1B2 lead to a more severe syndrome
might not be accurate. On the other hand, Kortüm et al.
screened a cohort of 24 ZLS patients, of which only 8
had mutations in KCNH1 and ATP6V1B2 suggesting fur-
ther the genetic heterogeneity in the ZLS disorder [18].
Conclusions
In summary, this study shows that the same KCNH1 muta-
tion can lead to both ZLS and TMBTS. The phenotypic
variability could be the result of a modifier gene or genes,
and identification of such genes would be of great import-
ance. A careful analysis of genetic polymorphisms in vari-
ous loci should be taken into consideration for clinical
diagnosis. Further investigations are needed to confirm if
ATP6V1B2 mutations lead to a more severe phenotype.
Abbreviations
ID, intellectual disability; TMBTS, Temple-Baraitser syndrome; WGS, whole
genome sequencing; ZLS, Zimmermann-Laband syndrome
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